Trial Details
COMPLETEDBasic Information
| Clinical ID | c1117 |
|---|---|
| Identifier | NCT01759056 |
| Trial Title | Evaluation of an Oral Anti-TNF Antibody in Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: AVX 470|DRUG: Placebo |
Participant Information
| Sponsor | Avaxia Biologics, Incorporated |
|---|---|
| City | Anaheim |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2025-02-13 |
|---|---|
| Primary Completion Date | 2025-12-13 |
| Completion Date | 2025-12-13 |